Wolfgang Tilgen

Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

Mark R. Middleton, Jean‐Jacques Grob, Neil K. Aaronson et al. · Journal of Clinical Oncology · 2000 · 1.3K citations

Increased Serum Concentration of Angiogenic Factors in Malignant Melanoma Patients Correlates With Tumor Progression and Survival

Selma Ugurel, Gunter Rappl, Wolfgang Tilgen et al. · Journal of Clinical Oncology · 2001 · 400 citations

Risk Factors for Developing Cutaneous Melanoma and Criteria for Identifying Persons at Risk: Multicenter Case-Control Study of the Central Malignant Melanoma Registry of the German Dermatological Society

Claus Garbe, Sabine Krüger, Constantin E. Orfanos et al. · Journal of Investigative Dermatology · 1994 · 289 citations

German Dermatological Society, Melanoma, Clinical Epidemiology +8

Associated Factors in the Prevalence of More Than 50 Common Melanocytic Nevi, Atypical Melanocytic Nevi, and Actinic Lentigines: Multicenter Case-Control Study of the Central Malignant Melanoma Registry of the German Dermatolgocial Society

Claus Garbe, Sabine Krüger, Constantin E. Orfanos et al. · Journal of Investigative Dermatology · 1994 · 184 citations

Medicine, Melanoma, Pathology +8

Extracellular Tyrosinase mRNA within Apoptotic Bodies Is Protected from Degradation in Human Serum

Dirk O. Hasselmann, Gunter Rappl, Wolfgang Tilgen et al. · Clinical Chemistry · 2001 · 171 citations · Full text

Apoptosis, Cell Death, Pathology +23